News
-
-
-
PRESS RELEASE
Affluent Medical : 2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap
Affluent Medical reached major new milestones in executing its clinical roadmap in 2024, including transformative agreements and positive FDA feedback. Financial results show progress and strategic appointments -
PRESS RELEASE
Affluent Medical : RESULTATS ANNUELS 2024 : Affluent Medical franchit de nouveaux jalons clés dans l’exécution de sa feuille de route clinique
Affluent Medical franchit de nouveaux jalons clés dans l’exécution de sa feuille de route clinique en 2024, avec des accords stratégiques et des avancées réglementaires majeures -
PRESS RELEASE
2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap
Affluent Medical announces major milestones in its 2024 full-year results including transformative agreements, regulatory validations, and clinical advancements, positioning the company for market launch -
-
-
PRESS RELEASE
Affluent Medical progresse vers une étude clinique européenne sur le sphincter artificiel Artus pour le traitement de l'incontinence urinaire d'effort chez la femme.
Affluent Medical progresse vers une étude clinique européenne sur le sphincter artificiel Artus pour le traitement de l'incontinence urinaire d'effort chez la femme -
PRESS RELEASE
Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women.
Affluent Medical progresses towards European clinical study of Artificial Sphincter Artus for treating Urinary Stress Incontinence in Women. The upcoming SPHINX study will assess device safety and performance -
PRESS RELEASE
Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women
Affluent Medical progresses towards European clinical study of Artus artificial sphincter for treating urinary stress incontinence in women. Minimally invasive procedure feasibility confirmed